May 28th, 2020 - The efficacy and safety of GOCOVRI® 274 mg were evaluated in two Phase 3, randomized, placebo-controlled trials
Jul 24th, 2020 - The Food and Drug Administration granted accelerated approval to brexucabtagene autoleucel (TECARTUS, Kite, a Gilead Company), a CD19-directed genetically modified autologous T cell immunotherapy, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL).
Apr 30th, 2022 - Hand sanitizer to help reduce bacterial on the skin that could cause diseaseAntimicrobial
Apr 25th, 2022 - Hand sanitizer to help reduce bacteria on the skinAntimicrobial
Gocovri Prescribing Information, PI, Parkinson Disease, PD
The remdesivir clinical trial program was designed to answer multiple scientific questions in parallel, to rapidly evaluate the potential for remdesivir to treat COVID-19 patients.
Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
Feb 27th, 2022 - Irbesartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension. Irbesartan and hydrochlorothiazide tablets may be used in patients whose blood pressure is not adequately controlled on monotherapy. Irbesartan and hydrochlorothiazide tablets may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals. The ...
Jan 8th, 2022 - Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1.1) Levetiracetam is indicated for adjunctive therapy for the treatment of: •Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) •Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilep...
Jan 1st, 2022 - Hand sanitizer to help reduce bacterial on the skin that could cause diseaseAntimicrobial
Jan 1st, 2022 - Hand sanitizer to help reduce bacteria on the skinAntimicrobial
Jan 1st, 2022 - Bupropion hydrochloride extended-release tablets (XL) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient. (1) Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder ...
Dec 30th, 2021 - Hand Sanitizer to help reduce bacteria that potentially can cause disease. For use when soap and water are not available.Antiseptic, Hand Sanitizer
Dec 11th, 2021 - to help reduce bacteria on the skin.Antiseptic
Dec 6th, 2021 - Hand Sanitizer to help reduce bacteria that potentially can cause disease. For use when soap and water are not available.Antiseptic, Hand Sanitizer
Nov 1st, 2021 - When applied to chest and throat, temporarily relieves cough due to minor throat and bronchial irritations associated with the common cold On muscles and joints, temporarily relieves minor aches and painsCamphor: cough suppressant / topical analgesic Menthol: cough suppressant / topical analgesic Eucalyptus oil: cough suppressant
Eli Lilly and Company
Mar 10th, 2021 - INDIANAPOLIS, March 10, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the randomized, double-blind, placebo-controlled BLAZE-1 Phase 3 study, demonstrating bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together significantly reduced COVID-19 related hospitalizations and deaths ("events") in high-risk patients recently diagnosed with CO...
Learn about an FDA-approved continued treatment option for patients with AML in remission. Register to receive updates. See safety info & full Prescribing Info.
Info on PHESGO™(pertuzumab/trastuzumab/hyaluronidase-zzxf), See Safety & Boxed Warning. Newly Approved Treatment · Get Info on Dosing · Downloads Available Types: Prescribing Info, Product Guide, Downloadable Brochure
Learn More About VEKLURY® as an FDA Approved Treatment Option for Eligible Patients. Product Access Information and Resources for HCPs are Available Here. Product Access. Register for Updates. Dosing & Administration. HCP Resources. Patient Support for HCPs.